Metastatic Prostate Cancer Interventions added to androgen-deprivation therapy in men with
metastatic prostate cancer have recently been noted to increase survival. Decisions about …

Prostate cancer is an androgen-receptor–dependent disease, and the blocking of
androgenreceptor signaling is a hallmark of prostate-cancer therapeutics. Although most …

Purpose To provide treatment recommendations for men with metastatic castration-resistant
prostate cancer (CRPC). Methods The American Society of Clinical Oncology and Cancer …

Background Androgen-deprivation therapy (ADT) has been the backbone of treatment for
metastatic prostate cancer since the 1940s. We assessed whether concomitant treatment …

Simple Summary Prostate cancer is the most common tumor in men. Although there have
been many new developments in the last few years, metastatic castration resistant prostate …

It is obvious, as Murphy noted in the opening statement, that the weaker trials, as do rings in
a chain, determine the quality of the metaanalysis. He emphasized that the first workshop …

Purpose There is growing interest in the role of local therapies, including external beam
radiotherapy (RT), for men with metastatic prostate cancer (mPCa). We used the National …

Abstract Background: Metastatic prostate cancer (PCa) is associated with considerable
diminished overall survival (OS). Standard treatment for metastatic PCa has long been …

Since 1941, androgen deprivation therapy has been the primary treatment for metastatic
hormone‐sensitive prostate cancer. Androgen deprivation therapy consists of several …

Purpose: We sought to evaluate predictors of overall survival following progression after
systemic chemotherapy in men with metastatic castration-resistant prostate cancer …